XML 14 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) attributable to common stockholders $ (92,550) $ 2,771
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 17,007 20,336
Impairment charge 49,438 989
Deferred income taxes (3,286) (169)
Non-cash interest 223 264
Amortization of syndication contracts 339 358
Payments on syndication contracts (337) (366)
Non-cash stock-based compensation 12,422 17,053
(Gain) loss on marketable securities 110 94
(Gain) loss on disposal of property and equipment 206 (11)
Loss (gain) on the sale of businesses 45,139  
(Gain) loss on debt extinguishment 91 1,556
Change in fair value of contingent consideration (13,198) (8,939)
Net income (loss) attributable to redeemable noncontrolling interest - discontinued operations (2,779) 1
Net income (loss) attributable to noncontrolling interest - discontinued operations   (342)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 10,611 16,261
(Increase) decrease in prepaid expenses and other current assets, operating leases right of use asset and other assets (1,928) (7,199)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 40,414 26,460
Net cash provided by operating activities 61,922 69,117
Cash flows from investing activities:    
Proceeds from sale of businesses, net of cash divested (42,967) 83
Purchases of property and equipment (6,289) (19,881)
Purchase of a business, net of cash acquired   (6,930)
Purchases of marketable securities   (11,355)
Proceeds from sale of marketable securities 10,381 38,093
Proceeds from loan receivable 10,748  
Purchases of investments   (300)
Issuance of loan receivable   (13,636)
Net cash provided by (used in) investing activities (28,127) (13,926)
Cash flows from financing activities:    
Proceeds from stock option exercises   554
Tax payments related to shares withheld for share-based compensation plans (27) (158)
Payments on debt (20,275) (214,495)
Dividends paid (13,471) (13,182)
Distributions to noncontrolling interest (1,078) (3,380)
Payment of contingent consideration (14,300) (35,113)
Principal payments under finance lease obligation (110) (113)
Proceeds from borrowings on debt   212,420
Payments for debt issuance costs   (1,777)
Net cash provided by (used in) financing activities (49,261) (55,244)
Effect of exchange rates on cash, cash equivalents and restricted cash (2) (2)
Net increase (decrease) in cash, cash equivalents and restricted cash (15,468) (55)
Cash, cash equivalents and restricted cash:    
Beginning 106,509 111,444
Ending 91,041 111,389
Cash payments for:    
Interest 12,644 12,524
Income taxes 6,700 5,929
Supplemental disclosures of non-cash investing and financing activities:    
Capital expenditures financed through accounts payable, accrued expenses and other liabilities 653 1,064
Fair value of contingent consideration related to acquisitions and purchase of noncontrolling interest   1,854
Fair value of put and call option of redeemable noncontrolling interest   47,300
Note receivable (5,374)  
Dividends equivalents payable $ 1,475 $ 100